Investor
SymBiosis
SymBiosis Capital Management is a biotechnology venture capital firm based in Bentonville, Arkansas, focused on investing in biotherapeutics innovations for serious diseases. They target companies developing advanced therapeutic platforms that are nearing human trials.
Online destinations
Find SymBiosis online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
SymBiosis Capital Management is a biotechnology venture capital firm based in Bentonville, Arkansas. Founded in 2019 and publicly launched in October 2021, the firm focuses on investing in bioengineering innovations that have the potential for industrial scale and speed. They partner with companies developing groundbreaking solutions for life-threatening diseases, utilizing novel therapeutic platforms and designing for manufacturability. SymBiosis invests across various modalities, including biologics, cell therapy, genetic medicine, and small molecules, targeting companies with lead candidates reaching human proof-of-concept or expected to do so with their initial investment round.
Focus
SymBiosis invests in biotechnology companies across various modalities, including biologics, cell therapy, genetic medicine, and small molecules. They target companies that have lead candidates reaching human proof-of-concept or are expected to do so with their initial investment round, focusing on late pre-clinical through clinical stages.
Support
SymBiosis adds value to its portfolio companies by providing access to a network of industry experts and resources, facilitating faster market entry for biotherapeutics through initiatives like the BioAR Trial Accelerator, and supporting companies in navigating the complexities of clinical trials and regulatory approvals.
Questions
What are SymBiosis's investment criteria?
SymBiosis invests in biotechnology companies that are developing solutions for life-threatening diseases. They focus on companies with lead candidates that are reaching human proof-of-concept or are expected to do so with their initial investment round. The firm is agnostic to specific diseases, provided that the endpoints for approval are well-established and objective.
How can I apply or pitch to SymBiosis?
Founders interested in pitching to SymBiosis can visit their website at symbiosis.vc for more information on the application process. They encourage startups to present their innovative solutions and how they align with the firm's investment thesis.
What makes SymBiosis different from other venture capital firms?
SymBiosis distinguishes itself by focusing exclusively on biotechnology innovations that target life-threatening diseases. Their investment strategy emphasizes manufacturability and the potential for industrial scale, which is critical for biotherapeutics.
What is the geographic scope of SymBiosis's investments?
SymBiosis primarily invests in companies based in the United States, although their investment strategy is agnostic to specific geographic locations. They are open to opportunities that align with their focus on biotherapeutics.
What is the typical check size for investments?
SymBiosis typically invests between $5 million and $15 million in initial funding rounds, with the potential to scale investments to $30 million or more across multiple financing rounds.
What kind of support does SymBiosis provide to portfolio companies?
SymBiosis adds value to its portfolio companies by providing access to a network of industry experts and resources. They facilitate faster market entry for biotherapeutics through initiatives like the BioAR Trial Accelerator and support companies in navigating clinical trials and regulatory approvals.
Check your startup’s fit
Check your startup’s fit with SymBiosisSimilar investors
Organizations that do similar work to SymBiosis.
Investor
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
InvestorSequoia Capital is a venture capital firm based in Silicon Valley, established in 1972. It invests in technology companies at various stages, focusing on long-term partnerships with founders.
InvestorKleiner Perkins is a venture capital firm based in Menlo Park, California, founded in the 1970s. It partners with entrepreneurs across various sectors, providing capital and resources from inception to IPO.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works